within Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IX03_Iodine125iCc49MonoclonalAntibody;
model Iodine125iCc49MonoclonalAntibody 
   extends Pharmacolibrary.Drugs.ATC.V.V09IX03;

  annotation(Documentation(
    info ="<html><body><p>Iodine (125I) CC49-monoclonal antibody is a radiolabeled monoclonal antibody targeted against the tumor-associated glycoprotein TAG-72, used primarily in radioimmunodetection and radioimmunotherapy studies of various adenocarcinomas. It has been investigated in clinical trials for diagnostic imaging of cancer but is not widely approved or used in current routine clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult cancer patients (various carcinomas), after intravenous bolus administration of iodine (125I) CC49.</p><h4>References</h4><ol><li><p>Cook, CH, et al., &amp; Martin, EW (1996). Pharmacokinetics of iodine-125 CC49 monoclonal antibody in patients with colon cancer. <i>Cancer biotherapy &amp; radiopharmaceuticals</i> 11(6) 415–422. DOI:<a href=&quot;https://doi.org/10.1089/cbr.1996.11.415&quot;>10.1089/cbr.1996.11.415</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10851502/&quot;>https://pubmed.ncbi.nlm.nih.gov/10851502</a></p></li><li><p>Xiao, J, et al., &amp; Martin, E (2005). Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patients. <i>Cancer biotherapy &amp; radiopharmaceuticals</i> 20(1) 16–26. DOI:<a href=&quot;https://doi.org/10.1089/cbr.2005.20.16&quot;>10.1089/cbr.2005.20.16</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15778575/&quot;>https://pubmed.ncbi.nlm.nih.gov/15778575</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Iodine125iCc49MonoclonalAntibody;
